Duke Transplant Center -- Pilot & Feasibility Studies Award

Funding Agency:
Duke University

The Duke Transplant Center is pleased to announce the 2nd annual DTC Pilot and Feasibility Studies RFA, due May 15, 2021.

Through this funding opportunity announcement we aim to accomplish two specific objectives:

  1. to catalyze collaborations between investigators within and outside the DTC; and
  2. to identify and validate novel approaches for personalizing transplantation aiming at risk stratifying, monitoring, and enhancing transplant graft outcome.


We look forward to receiving your proposals in response to the funding announcement and your continued involvement in the transplant research community.

We welcome applications  across the spectrum of research that relate to our theme and support our ultimate goal of optimizing transplant organ longevity and improving quality of life of transplant recipients.


Funds are expected to begin July 1, 2021.

Full RFA

Eligibility Requirements

Clinical, translational, and basic research investigators with an M.D., Ph.D. or equivalent, and have a faculty position or a faculty sponsor within Duke University are all eligible to apply.  Additional eligibility also includes DTC direct report staff and transplant ancillary staff.  Investigators need to justify how the proposed studies relate to the broad mission of DTC and the two specific objectives of this announcement.  Preliminary data is encouraged but not crucial.  Applications that foster collaborations between DTC and non-DTC investigators are particularly encouraged.



Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 15, 2021